Bromodomain Inhibition Reveals FGF15/19 As a Target of Epigenetic Regulation and Metabolic Control

Chisayo Kozuka(RIKEN Center for Integrative Medical Sciences), Mary‐Elizabeth Patti(Joslin Diabetes Center)
Diabetes
January 31, 2022
Cited by 10


Related Papers